Xcout Intel
Focal Medical, Inc.
Focal Medical develops and manufactures the Focal One HIFU Robotic System, a non-invasive medical device that utilizes high-intensity focused ultrasound technology to precisely target and ablate prostate tissue. The company serves urologists and healthcare facilities by providing equipment for prostate cancer management that preserves healthy surrounding tissue and minimizes side effects for patients.
Subscribe to see Focal Medical, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Focal Medical, Inc. at a glance
Focal Medical, Inc. is a medical device company headquartered in United States. Its most recent funding round, Seed, raised $950,000 in February 2024. Xcout tracks 7 named people at Focal Medical, Inc., including Ryan Rhodes (Chief Executive Officer).
Focal Medical, Inc. leadership
- Ryan RhodesChief Executive Officer
- Ken MobeckChief Financial Officer
- Steve AnnenExecutive Vice President, Marketing & Product Management
- Hugo EmbertVice President, Marketing & Reimbursement
- Michelle MontakhabVice President, People, Talent & Culture
- Mohan NathanSr. Vice President, US Sales
1 more named person on record for Focal Medical, Inc., with roles, board committees and tenure — see the full roster →
Focal Medical, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $950,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Focal Medical, Inc. competitors
A few of Focal Medical, Inc.'s closest competitors — see the full list of competitors and alternatives →
Focal Therapeutics provides the Focal One robotic system, which utilizes high-intensity focused ultrasound (HIFU) technology to non-invasively target and ablate prostate tissue for prostate cancer patients. The system is designed for urologists to precisely treat targeted lesions while sparing healthy surrounding tissue and minimizing side effects.
Francis Medical, Inc. develops medical technology for targeted tissue ablation, including the Vanquish System designed for water vapor prostate treatment.
MedicaMetrix develops medical devices for prostate health, specifically offering the ProstaMetrix platform to measure prostate volume and calculate Prostate Specific Antigen Density (PSAD) during routine clinical examinations. The company serves urologists and healthcare professionals by providing tools for the early detection and ongoing monitoring of prostate conditions such as prostate cancer and BPH.
SpectraCure is a medical technology company that develops a precision treatment system for localized prostate cancer and other internal solid tumors. The company utilizes photodynamic therapy (PDT) combined with a proprietary dose-planning platform to offer targeted, minimally invasive treatments for prostate cancer patients.
URO-1, Inc. is a privately held medical device company established in 2017 and based in Greensboro, North Carolina. The company develops and manufactures surgical solutions and instruments for biopsy procedures, specifically focusing on prostate and soft tissue cancer diagnostics.
Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and uterine fibroids, as well as providing palliative pain relief. The company markets its solutions across Canada, Germany, the United States, and Finland. Its flagship product, the TULSA-PRO system, is specifically designed for use with magnetic resonance imaging (MRI) scanners within hospital settings and other treatment centers. Additionally, Profound Medical offers Sonalleve, a therapeutic platform that addresses uterine fibroids – including through non-invasive methods – and provides palliative relief for pain linked to bone metastases. The company's primary operations are headquartered in Mississauga, Canada.
Get Focal Medical, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Focal Medical, Inc. in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access